First in pediatrics phase 1 study of CD40 agonistic monoclonal antibody APX005M in pediatric subjects with recurrent/refractory brain tumors Meeting Abstract


Authors: Lindsay, H.; Onar-Thomas, A.; Kocak, M.; Poussaint, T. Y.; Dhall, G.; Broniscer, A.; Vinitsky, A.; MacDonald, T.; Trifan, O.; Fangusaro, J.; Dunkel, I.
Abstract Title: First in pediatrics phase 1 study of CD40 agonistic monoclonal antibody APX005M in pediatric subjects with recurrent/refractory brain tumors
Meeting Title: 19th International Symposium on Pediatric Neuro-Oncology (ISPNO 2020)
Journal Title: Neuro-Oncology
Volume: 22
Issue: Suppl. 3
Meeting Dates: 2020 Dec 13-16
Meeting Location: Karuizawa, Japan
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2020-12-01
Start Page: iii304
Language: English
ACCESSION: WOS:000606080100128
PROVIDER: wos
DOI: 10.1093/neuonc/noaa222.127
Notes: Meeting Abstract: EPCT-02. PBTC-051 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ira J Dunkel
    371 Dunkel
Related MSK Work